Reviva Pharmaceuticals Holdings, Inc. Earnings Per Share (Basic)
Reviva Pharmaceuticals Holdings, Inc. (RVPH) reported Earnings Per Share (Basic) of -$0.19 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-12
- Reviva Pharmaceuticals Holdings, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.19.
- Reviva Pharmaceuticals Holdings, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.46.
- Reviva Pharmaceuticals Holdings, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.06.
- Reviva Pharmaceuticals Holdings, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$2.40.
- Reviva Pharmaceuticals Holdings, Inc. earnings per share, basic for fiscal 2025 was -$5.48.
- Reviva Pharmaceuticals Holdings, Inc. earnings per share, basic for fiscal 2024 was -$17.73.
- Reviva Pharmaceuticals Holdings, Inc. earnings per share, basic for fiscal 2023 was -$1.65.
- Reviva Pharmaceuticals Holdings, Inc. earnings per share, basic for fiscal 2022 was -$1.45.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.19 10-Q · filed 2026-08-12 | -$0.56 10-Q · filed 2026-08-12 | ||||||
| 2026-03-31 | -$0.46 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | -$5.48 10-K · filed 2026-03-30 | |||||||
| 2025-09-30 | -$0.06 10-Q · filed 2025-11-13 | -$0.29 10-Q · filed 2025-11-13 | ||||||
| 2025-06-30 | -$2.40 10-Q · filed 2026-08-12 | -$0.12 10-Q · filed 2025-08-14 | -$5.01 10-Q · filed 2026-08-12 | -$0.25 10-Q · filed 2025-08-14 | ||||
| 2025-03-31 | -$2.61 10-Q · filed 2026-05-13 | -$0.13 10-Q · filed 2025-05-15 | ||||||
| 2024-12-31 | -$17.73 10-K · filed 2026-03-30 | -$0.90 10-K · filed 2025-04-03 | ||||||
| 2024-09-30 | -$0.25 10-Q · filed 2025-11-13 | -$0.75 10-Q · filed 2025-11-13 | ||||||
| 2024-06-30 | -$0.26 10-Q · filed 2025-08-14 | -$0.51 10-Q · filed 2025-08-14 | ||||||
| 2024-03-31 | -$0.25 10-Q · filed 2025-05-15 | |||||||
| 2023-12-31 | -$1.65 10-K · filed 2025-04-03 | |||||||
| 2023-09-30 | -$0.48 10-Q · filed 2024-11-14 | -$0.44 10-Q · filed 2023-11-14 | -$1.32 10-Q · filed 2024-11-14 | -$1.30 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | -$0.52 10-Q · filed 2024-08-14 | -$0.55 10-Q · filed 2023-08-14 | -$0.84 10-Q · filed 2024-08-14 | -$0.86 10-Q · filed 2023-08-14 | ||||
| 2023-03-31 | -$0.31 10-Q · filed 2024-05-14 | -$0.30 10-Q · filed 2023-05-15 | ||||||
| 2022-12-31 | -$1.45 10-K · filed 2024-04-15 | -$1.25 10-K · filed 2023-03-30 | ||||||
| 2022-09-30 | -$0.28 10-K · filed 2024-04-15 | -$0.18 10-Q · filed 2022-11-14 | -$1.02 10-K · filed 2024-04-15 | -$0.87 10-Q · filed 2022-11-14 | ||||
| 2022-06-30 | -$0.29 10-Q · filed 2023-08-14 | -$0.69 10-Q · filed 2023-08-14 | ||||||
| 2022-03-31 | -$0.40 10-Q · filed 2023-05-15 | |||||||
| 2021-12-31 | -$0.58 10-K · filed 2023-03-30 | |||||||
| 2021-09-30 | -$0.12 10-Q · filed 2022-11-14 | -$0.36 10-Q · filed 2022-11-14 | ||||||
| 2021-06-30 | -$0.12 10-Q · filed 2022-08-15 | -$0.23 10-Q · filed 2022-08-15 | ||||||
| 2021-03-31 | -$0.10 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |